Back to search

Article

PKLR-modulating compounds show promising effects for the treatment of hepatocellular carcinoma

2024-10-30

Abstract excerpt

<title>Abstract</title> <p>The pyruvate kinase L/R (PKLR) enzyme was associated with the progression of hepatocellular carcinoma (HCC) and metabolic dysfunction-associated fatty liver disease (MAFLD) and identified as a potential drug target. Here, we first demonstrated the anti-HCC effects of recently developed six PKLR-modulating compounds, including SET135, SET156, SET158, SET159, SET171, and SET172 and JNK-IN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0cc7ba52-80e5-5fef-a4a1-766fd82a1b66
DOI
10.21203/rs.3.rs-5298615/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PKLR-modulating compounds show promising effects for the treatment of hepatocellular carcinomaDOI 10.21203/rs.3.rs-5298615/v1
Select a neighboring publication to make it the new centre.